What are the short-term price targets set by analysts for MRK's stock?

The short-term price targets set by analysts for Merck & Co., Inc. (MRK) stock are as follows: 1. **Jefferies**: Raised its price target to $141 from $138, maintaining a Buy rating. 2. **UBS**: Reiterated its Buy rating and set a price target of $105 following Merck's acquisition of Verona Pharma. 3. **Morgan Stanley**: Lowered its price target to $98 from $99, keeping a Hold rating. The average of these targets is approximately $101.50, with a high estimate of $141 and a low estimate of $82. This suggests a potential upside from the current price of $79.48, with analysts indicating a range of possible short-term outcomes.